Chemokines and chemokine receptors during COVID-19 infection BA Khalil, NM Elemam, AA Maghazachi Computational and structural biotechnology journal 19, 976-988, 2021 | 185 | 2021 |
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis NM Elemam, S Hannawi, AA Maghazachi Immunotargets and therapy 2020 (9), 43—56, 2020 | 100 | 2020 |
Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk MY Hachim, BA Khalil, NM Elemam, AA Maghazachi Journal of Leucocyte Biology 108 (1), 323-338, 2020 | 62 | 2020 |
Innate lymphoid cells (ILCs) as mediators of inflammation, release of cytokines and lytic molecules NM Elemam, S Hannawi, AA Maghazachi Toxins 9 (12), 398, 2017 | 56 | 2017 |
Targeting chemokines and chemokine receptors in multiple sclerosis and experimental autoimmune encephalomyelitis S Dhaiban, M Al-Ani, NM Elemam, AA Maghazachi Journal of inflammation research, 619-633, 2020 | 44 | 2020 |
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 42 | 2024 |
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 41 | 2024 |
Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates NM Elemam, H Hannawi, I Al Salmi, KB Naeem, F Alokaily, S Hannawi Saudi medical journal 42 (2), 170, 2021 | 39 | 2021 |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 35 | 2024 |
Understanding the role of innate immune cells and identifying genes in breast cancer microenvironment I Shihab, BA Khalil, NM Elemam, IY Hachim, MY Hachim, RA Hamoudi, ... Cancers 12 (8), 2226, 2020 | 33 | 2020 |
Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models RY Mekky, N El-Ekiaby, SA El Sobky, NM Elemam, RA Youness, ... Archives of Virology, 2019 | 33 | 2019 |
Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells JS Muhammad, MN Jayakumar, NM Elemam, T Venkatachalam, TK Raju, ... ImmunoTargets and Therapy 8, 29, 2019 | 33 | 2019 |
CXCL10 chemokine: a critical player in RNA and DNA viral infections NM Elemam, IM Talaat, AA Maghazachi Viruses 14 (11), 2445, 2022 | 31 | 2022 |
Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis S Dhaiban, M Al-Ani, NM Elemam, MH Al-Aawad, Z Al-Rawi, ... Sci 3 (1), 12, 2021 | 29 | 2021 |
Complement system: an immunotherapy target in colorectal cancer IM Talaat, NM Elemam, M Saber-Ayad Frontiers in Immunology 13, 810993, 2022 | 27 | 2022 |
Clinical and laboratory profile of hospitalized symptomatic COVID-19 patients: case series study from the first COVID-19 center in the UAE S Hannawi, H Hannawi, KB Naeem, NM Elemam, MY Hachim, IY Hachim, ... Frontiers in cellular and infection microbiology 11, 632965, 2021 | 24 | 2021 |
Drugs for multiple sclerosis activate natural killer cells: do they protect against COVID-19 infection? M Al-Ani, NM Elemam, JE Hundt, AA Maghazachi Infection and Drug Resistance, 3243-3254, 2020 | 24 | 2020 |
Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor RY Mekky, NM El-Ekiaby, MT Hamza, NM Elemam, G Esmat, AI Abdelaziz Journal of Infection 70 (1), 78-87, 2015 | 24 | 2015 |
Circulating soluble ACE2 and upstream microRNA expressions in serum of type 2 diabetes mellitus patients NM Elemam, H Hasswan, H Aljaibeji, N Sulaiman International journal of molecular sciences 22 (10), 5263, 2021 | 23 | 2021 |
Reduced Expression of PLCXD3 Associates With Disruption of Glucose Sensing and Insulin Signaling in Pancreatic β-Cells H Aljaibeji, D Mukhopadhyay, AK Mohammed, S Dhaiban, MY Hachim, ... Frontiers in Endocrinology 10, 735, 2019 | 21 | 2019 |